SG Americas Securities, LLC - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2023$316
-49.4%
23,600
+17.4%
0.00%
-20.0%
Q2 2023$624
+387.5%
20,100
+157.7%
0.01%
+400.0%
Q1 2023$128
-100.0%
7,800
-59.4%
0.00%
-91.7%
Q4 2020$2,212,000
+211.1%
19,200
+57.4%
0.01%
+140.0%
Q3 2020$711,000
+10.7%
12,200
-65.1%
0.01%
-16.7%
Q1 2020$642,000
-10.1%
35,000
-58.1%
0.01%
-14.3%
Q4 2019$714,000
-86.9%
83,500
+28.5%
0.01%
-84.4%
Q3 2019$5,450,000
+9.6%
65,000
-17.7%
0.04%
+32.4%
Q2 2019$4,973,000
+129.2%
79,000
-28.4%
0.03%
+70.0%
Q1 2019$2,170,000
-12.3%
110,300
-25.0%
0.02%
-9.1%
Q4 2018$2,474,000
+19.5%
147,000
-1.1%
0.02%
+46.7%
Q3 2018$2,071,000
-49.3%
148,700
+17.5%
0.02%
-59.5%
Q2 2018$4,082,000
-22.1%
126,600
+4.2%
0.04%
-11.9%
Q1 2018$5,243,000
+251.9%
121,500
+378.3%
0.04%
+200.0%
Q4 2017$1,490,000
+30.2%
25,4000.0%0.01%
+40.0%
Q3 2017$1,144,000
-49.4%
25,400
+4.5%
0.01%
-37.5%
Q1 2016$2,262,000
+92.8%
24,300
-70.8%
0.02%
+100.0%
Q4 2015$1,173,000
-52.8%
83,200
+38.4%
0.01%
-46.7%
Q3 2015$2,484,000
+87.6%
60,100
-15.2%
0.02%
+66.7%
Q2 2015$1,324,000
+1847.1%
70,900
+41.8%
0.01%
Q4 2014$68,000
-95.0%
50,0000.0%0.00%
-100.0%
Q3 2014$1,364,00050,0000.01%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q1 2021
NameSharesValueWeighting ↓
IMC-Chicago, LLC 73,100$35,315,0000.04%
GROUP ONE TRADING, L.P. 46,700$22,561,0000.04%
SIMPLEX TRADING, LLC 365$17,633,0000.02%
SG Americas Securities, LLC 19,200$2,212,0000.01%
JPMORGAN CHASE & CO 22,500$10,870,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders